Search Results - "Salmon, David P"

Alzheimer's Disease: Past, Present, and Future by Bondi, Mark W, Edmonds, Emily C, Salmon, David P

“…Although dementia has been described in ancient texts over many centuries (e.g., "Be kind to your father, even if his mind fail him." - Old Testament: Sirach…”
Get more information

The A4 study: stopping AD before symptoms begin? by Sperling, Reisa A, Rentz, Dorene M, Johnson, Keith A, Karlawish, Jason, Donohue, Michael, Salmon, David P, Aisen, Paul

“…A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer's disease dementia should provide insights into whether…”
Get more information

Neuropsychological Assessment of Dementia by SALMON, David P, BONDI, Mark W

“…Neuropsychological studies show that cognitive deficits associated with Alzheimer's disease (AD) are distinct from age-associated cognitive decline…”
Get full text

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change by Smirnov, Denis S., Ashton, Nicholas J., Blennow, Kaj, Zetterberg, Henrik, Simrén, Joel, Lantero-Rodriguez, Juan, Karikari, Thomas K., Hiniker, Annie, Rissman, Robert A., Salmon, David P., Galasko, Douglas

“…Plasma biomarkers related to amyloid, tau, and neurodegeneration (ATN) show great promise for identifying these pathological features of Alzheimer’s Disease…”
Get full text

Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment by Edmonds, Emily C, Delano-Wood, Lisa, Galasko, Douglas R, Salmon, David P, Bondi, Mark W

“…Subjective cognitive complaints are a criterion for the diagnosis of mild cognitive impairment (MCI), despite their uncertain relationship to objective memory…”
Get more information

Early versus late MCI: Improved MCI staging using a neuropsychological approach by Edmonds, Emily C., McDonald, Carrie R., Marshall, Anisa, Thomas, Kelsey R., Eppig, Joel, Weigand, Alexandra J., Delano-Wood, Lisa, Galasko, Douglas R., Salmon, David P., Bondi, Mark W.

“…The Alzheimer's Disease Neuroimaging Initiative (ADNI) separates “early” and “late” mild cognitive impairment (MCI) based on a single memory test. We compared…”
Get full text

Effect of Knowledge of APOE Genotype on Subjective and Objective Memory Performance in Healthy Older Adults by Lineweaver, Tara T., Bondi, Mark W., Galasko, Douglas, Salmon, David P.

“…Older adults who know they have the e4 allele of the apolipoprotein E (APOE) gene, a risk factor for Alzheimer’s disease, perform worse on objective tests of…”
Get full text

Quantification of Five Neuropsychological Approaches to Defining Mild Cognitive Impairment by Jak, Amy J., Ph.D, Bondi, Mark W., Ph.D, Delano-Wood, Lisa, Ph.D, Wierenga, Christina, Ph.D, Corey-Bloom, Jody, M.D., Ph.D, Salmon, David P., Ph.D, Delis, Dean C., Ph.D

“…Objectives: Operational definitions of cognitive impairment have varied widely in diagnosing mild cognitive impairment (MCI). Identifying clinical subtypes of…”
Get full text

Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors by Edmonds, Emily C, Delano-Wood, Lisa, Clark, Lindsay R, Jak, Amy J, Nation, Daniel A, McDonald, Carrie R, Libon, David J, Au, Rhoda, Galasko, Douglas, Salmon, David P, Bondi, Mark W

“…Abstract Background We assessed whether mild cognitive impairment (MCI) subtypes could be empirically derived within the Alzheimer's Disease Neuroimaging…”
Get full text

TDP‐43 Pathology Exacerbates Cognitive Decline in Primary Age‐Related Tauopathy by Smirnov, Denis S., Salmon, David P., Galasko, Douglas, Edland, Steven D., Pizzo, Donald P., Goodwill, Vanessa, Hiniker, Annie

“…Objective Primary age‐related tauopathy (PART) refers to tau neurofibrillary tangles restricted largely to the medial temporal lobe in the absence of…”
Get full text

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease by Rafii, Michael S, Baumann, Tiffany L, Bakay, Roy A.E, Ostrove, Jeffrey M, Siffert, Joao, Fleisher, Adam S, Herzog, Christopher D, Barba, David, Pay, Mary, Salmon, David P, Chu, Yaping, Kordower, Jeffrey H, Bishop, Kathie, Keator, David, Potkin, Steven, Bartus, Raymond T

“…Abstract Background Nerve growth factor (NGF) is an endogenous neurotrophic-factor protein with the potential to restore function and to protect degenerating…”
Get full text

Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults by Nation, Daniel A, Edmonds, Emily C, Bangen, Katherine J, Delano-Wood, Lisa, Scanlon, Blake K, Han, S Duke, Edland, Steven D, Salmon, David P, Galasko, Douglas R, Bondi, Mark W

“…Increased pulse pressure associated with age-related arterial stiffening increases risk for Alzheimer dementia but the mechanism responsible for this…”
Get more information

Improving dementia care: The role of screening and detection of cognitive impairment by Borson, Soo, Frank, Lori, Bayley, Peter J, Boustani, Malaz, Dean, Marge, Lin, Pei-Jung, McCarten, J. Riley, Morris, John C, Salmon, David P, Schmitt, Frederick A, Stefanacci, Richard G, Mendiondo, Marta S, Peschin, Susan, Hall, Eric J, Fillit, Howard, Ashford, J. Wesson

“…Abstract The value of screening for cognitive impairment, including dementia and Alzheimer's disease, has been debated for decades. Recent research on causes…”
Get full text

Specific measures of executive function predict cognitive decline in older adults by Clark, Lindsay R, Schiehser, Dawn M, Weissberger, Gali H, Salmon, David P, Delis, Dean C, Bondi, Mark W

“…Decline in executive function has been noted in the prodromal stage of Alzheimer's disease (AD) and may presage more global cognitive declines. In this…”
Get more information

Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease by Bangen, Katherine J, Nation, Daniel A, Delano-Wood, Lisa, Weissberger, Gali H, Hansen, Lawrence A, Galasko, Douglas R, Salmon, David P, Bondi, Mark W

“…Abstract We examined the relationships of antemortem vascular risk factors to postmortem cerebrovascular and Alzheimer's disease (AD) pathologies. Eighty-four…”
Get full text

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam) by Feldman, Howard H, Luchsinger, José A, Léger, Gabriel C, Taylor, Curtis, Jacobs, Diane M, Salmon, David P, Edland, Steven D, Messer, Karen, Revta, Carolyn, Flowers, Sarah A, Jones, Kerry S, Koulman, Albert, Yarasheski, Kevin E, Verghese, Philip B, Venkatesh, Venky, Zetterberg, Henrik, Durant, January, Lupo, Jody-Lynn, Gibson, Gary E

“…Benfotiamine provides an important novel therapeutic direction in Alzheimer's disease (AD) with possible additive or synergistic effects to amyloid targeting…”
Get full text

Effects of Chronic Stress on Memory Decline in Cognitively Normal and Mildly Impaired Older Adults by Peavy, Guerry M., Salmon, David P., Jacobson, Mark W., Hervey, Aaron, Gamst, Anthony C., Wolfson, Tanya, Patterson, Thomas L., Goldman, Sherry, Mills, Paul J., Khandrika, Srikrishna, Galasko, Douglas

“…Objective: The literature provides evidence of a strong relationship between greater stress and memory loss, but few studies have examined this relationship…”
Get full text

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease by Tuszynski, Mark H, Thal, Leon, Pay, Mary, Salmon, David P, U, Hoi Sang, Bakay, Roy, Patel, Piyush, Blesch, Armin, Vahlsing, H Lee, Ho, Gilbert, Tong, Gang, Potkin, Steven G, Fallon, James, Hansen, Lawrence, Mufson, Elliott J, Kordower, Jeffrey H, Gall, Christine, Conner, James

“…Cholinergic neuron loss is a cardinal feature of Alzheimer disease. Nerve growth factor (NGF) stimulates cholinergic function, improves memory and prevents…”
Get full text

What Causes the Bilingual Disadvantage in Verbal Fluency? The Dual-Task Analogy by Sandoval, Tiffany C, Gollan, Tamar H, Ferreira, Victor S, Salmon, David P

“…We investigated the consequences of bilingualism for verbal fluency by comparing bilinguals to monolinguals, and dominant versus non-dominant-language fluency…”
Get more information

Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative by Thomas, Kelsey R., Eppig, Joel S., Weigand, Alexandra J., Edmonds, Emily C., Wong, Christina G., Jak, Amy J., Delano-Wood, Lisa, Galasko, Douglas R., Salmon, David P., Edland, Steven D., Bondi, Mark W.

“…We examined reasons for low mild cognitive impairment (MCI)-to-cognitively normal (CN) reversion rates in the Alzheimer's Disease Neuroimaging Initiative…”
Get full text